Igenica Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.igenica.com
A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- Igenica Biotherapeutics, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT02040506
- Locations
- 🇺🇸
UCSD Medical Center / Thornton Hospital, La Jolla, California, United States
🇺🇸Indiana Blood and Marrow Transplantation Clinic, Indianapolis, Indiana, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath